BioLargo subsidiary Clyra Medical Technologies said Wednesday it closed a financing deal with Sanatio Capital for $750,000 equity up front and a commitment for a $5 million operating line of credit. Fund will go to support Clyra’s advanced wound care products, with the company hoping to submit FDA 510(k) applications sometime this year, according to […]
